Caxton Associates
Caxton Associates LP is a $7.6 billion New York-based hedge fund, founded in 1983 by Bruce Kovner.
Caxton Associates' primary business is to manage client and proprietary capital through global macro hedge fund strategies as well as other alternative investment disciplines.
Caxton employs over 205 people at its offices in New York, Princeton, NJ and London.
View Older Stories View More Recent Stories
-
N. America average daily FX volume rose in April 2021 -NY Fed FX survey
-
Paragon Technologies News Release
-
Paragon Technologies News Release
-
Paragon Technologies News Release
-
WM Technology, Inc (MAPS) Announces it Board of Directors
-
WM Technology, Inc. Announces Public Company Board of Directors
-
Analysis: Investors pivot to Powell after more hot U.S. inflation data
-
US June CPI comes in hotter than expected
-
Dollar rises as U.S. data shows inflation running hot
-
Fed's Powell sticks to transient inflation scenario on Capitol Hill
-
Fed will not raise rates on inflation fears alone, Powell says
-
Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases
-
Form 13F-HR CAXTON ASSOCIATES LP For: Mar 31
-
Investment firms took positions on stocks hit by Archegos implosion, Gamestop
-
Form 13F-HR CAXTON CORP For: Mar 31
-
Form D/A HedgeForum Caxton, Ltd.
-
Form D/A Caxton Macro (USA) LLC
-
Form D/A Caxton Global Investment
-
Form D/A Caxton Dynamis (USA)
-
Form D/A Caxton Advantage (USA)
-
Form SC 13G Savara Inc Filed by: CAXTON CORP
-
Form SC 13G/A Sierra Oncology, Inc. Filed by: CAXTON CORP
-
Form SC 13G/A CTI BIOPHARMA CORP Filed by: CAXTON CORP
-
Form SC 13G Addex Therapeutics Ltd. Filed by: CAXTON CORP
-
Form 13F-HR CAXTON ASSOCIATES LP For: Dec 31
-
Form SC 13G/A SCYNEXIS INC Filed by: CAXTON CORP
-
Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: CAXTON CORP
-
Form SC 13G/A Cardiff Oncology, Inc. Filed by: CAXTON CORP
-
Form 13F-HR CAXTON CORP For: Dec 31
-
Dollar retreats as riskier currencies recover
-
Analysis-U.S. currency manipulator tag for Switzerland unlikely to deter FX approach
-
Analysis-U.S. currency manipulator tag for Switzerland unlikely to deter FX approach
-
Author Simplifies the Spelling of the English Language in New Book
-
Kelly Griffin Joins Sun Capital Partners as Managing Director – Head of Investor Relations; Angela Geffre Appointed Chief Human Resources Officer
-
Caledonia Mining Corporation Plc: Completion of Equipping Phase of Central Shaft
-
Caledonia Mining Corporation Plc: Completion of Equipping Phase of Central Shaft
-
Form 13F-HR CAXTON ASSOCIATES LP For: Sep 30
-
Form 13F-HR CAXTON CORP For: Sep 30
-
Form SC 13G Rezolute, Inc. Filed by: CAXTON CORP
-
Form SC 13G CTI BIOPHARMA CORP Filed by: CAXTON CORP
-
Form SC 13D/A Strongbridge Biopharma Filed by: CAXTON CORP
-
Form 13F-HR CAXTON ASSOCIATES LP For: Jun 30
-
Big U.S. funds gorged on tech stocks and gold in second quarter: 13F filings
-
Form 13F-HR/A CAXTON CORP For: Jun 30
-
Form 13F-HR CAXTON CORP For: Jun 30
-
Form D/A Caxton Global Investment
-
Form D/A Caxton Macro (USA) LLC
-
Form D/A Caxton Advantage (USA)
-
King dollar's decline ripples across the globe
-
Voya Investment Management Hires Tom Frost as Head of EMEA Insurance and Pension Solutions

